Scientific Paper: A Randomized, Double-blind, Head-to-head, Crossover Study Comparing the Clinical Safety and Efficacy of Abobotulinumtoxina with Onabotulinumtoxina When Treating Adults with Upper Limb Spasticity

Wednesday, May 20, 2026

11:15 AM - 11:30 AM PT

Location: 118

Speaker(s)

Alberto Esquenazi, MD

Chief Clinical Officer
Jefferson Moss-Magee Rehabilitation

COI
Unless noted below there are none.
Alberto Esquenazi, MD – Disclosed research support (Ipsen)